Irina Gaberman

FDA investigator

Appears on 8 documents from 2011 to 2025, most often at sites in New York. Most often cites written procedures; deviations (21 CFR 211.100).

8
Documents on file
6.8
Observations per 483
2011
First seen
2025
Most recent

What they cite most

From 54 observations

Activity by year

2011: 1, 2017: 1, 2020: 1, 2023: 2, 2024: 2, 2025: 1

Where

New York 3 · Japan 1 · New Jersey 1 · Spain 1

Is Irina Gaberman coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
483 Americord Registry LLCNov 17, 2025 · Somerset, New Jersey
483 FDA Form 438 Grifols, Barcelona, Spain, July 2024Jul 26, 2024 · Paret s Del Valles
483 Laboratorios Grifols, S.A.Jul 26, 2024 · Parets del Valles, Spain
483 FDA Form 483 FUJINOMIYA FACTORY OF TERUMO CORP Fujinomiya, Japan May 2023May 19, 2023 · Fujinomiya, Japan
483 Form 483, May 12, 2023May 12, 2023
483 New York Blood Center, Inc.Feb 11, 2020 · Rye, New York
483 New York Blood Center, Inc.Sep 29, 2017 · Rye, New York

About this profile

What does Irina Gaberman inspect?

Irina Gaberman appears on 8 documents on file covering 4 sites, most often in New York.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.160 and 21 CFR 1271.60.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Irina Gaberman is dated Nov 17, 2025.